Imagine growing a steak in a lab without needing to keep taking samples from a living cow. This tech uses a special 'forever' cell line and a nutrient cocktail that tells those cells to grow and knit together into real muscle. It's like providing a perfect blueprint and the right fuel to build meat faster and cheaper.
Cultivated meat faces high costs and poor quality because cells must be constantly harvested from animals and struggle to mature into real muscle tissue at scale.
A stable, immortalized bovine myoblast cell line (PF-B8) and specialized media supplements (PF-S1, PF-S2) for muscle maturation.
If you are a lab-grown meat startup dealing with high production costs and poor texture — this project developed a stable bovine myoblast cell line and media supplements that mimic natural muscle development. This allows for better scale-up and improved organoleptic quality.
If you are an alternative protein supplier dealing with inefficient cell differentiation — this project developed PF-S1 and PF-S2 media supplements. These tools drive the fusion of cells into contractile muscle, increasing the protein content and quality of the final product.
If you are an infrastructure provider dealing with the inability to scale 3D growth protocols — this project developed optimized 3D growth protocols and cell lines. This enables the transition to industrial-scale production environments.
It reduces costs by using a spontaneously immortalized cell line, removing the need to continuously source cells from live animals, and optimizing media supplements for efficiency.
Yes, the project specifically aims to optimize combined cell-line and supplement solutions for 3D production techniques to reach TRL6 and validate them with at least 3 potential clients.
The technology is protected by a patent, and the startup was incorporated after receiving the licensing of this patent.
The project runs from 2024-04-01 to 2026-03-31, aiming to bring the solution to TRL6 by the end of the period.
Based on available project data, the media supplements drive highly effective fusion and maturation into contractile muscle, mimicking natural development to satisfy consumer nutritional and organoleptic needs.
The project is led by a single SME, PROFUSE TECHNOLOGY LTD, based in Israel. With a 100% industry ratio and no university or research center partners, the project is lean and focused entirely on commercialization and technical scale-up rather than basic research.
Contact PROFUSE TECHNOLOGY LTD via their corporate channels in Israel.
Contact us to connect with the PROFUSE team for licensing or partnership opportunities.
